A recent study report has suggested to have found an anti-parasitic drug that claims to completely kill the Coronavirus lurking in a host cell within 48 hours. The study indicates that there has been a considerable amount of reduction in the virus cells within 24 hours of utilization of the said drug. The availability of this drug throughout the world makes it the most viable option.
The infamous drug Ivermectin is an FDI-approved anti-parasitic drug that has proved effective against a number of viruses such as Dengue, HIV and Influenza. However, it is still unknown how Ivermectin is calibrating through the virus. It is assumed that the drug can stop the virus from restricting the host cells’ ability to fight against it.
The study is considered to be a joint-operation between Monash Biomedicine Discovery Institute and the Peter Doherty Institute of Infection and Immunity. It identified Ivermectin as the drug that may help in controlling the effects of COVID-19’s growth in cell culture. It was observed that the rate of results in the study showed quite impressive remarks.
“We found that even a single dose could essentially remove all viral RNA (effectively removed all genetic material of the virus) by 48 hours and that even at 24 hours there was a really significant reduction in it,” says Dr. Kylie Wagstaff of Monash Biomedicine Discovery Institute. This study has already been published in Antiviral Research and the next thing for the researchers to undertake is to figure out the right human dosage for the anti-parasitic drug.
Frankly speaking, it is going to be a while before a fully functional and clinically proven, not only tested vaccine is available broadly for the public use. Essentially, Ivermectin has to prove its worth by going through pre-clinical testing and clinical trials for which funding is required, before being utilized as a weapon in the fight against the novel coronavirus.
The most important factor that might help with the emergent timeline is its global availability. As the drug has already being utilized in various countries, the supply chain for the transportation of it will not have to be established once the final drug is made available to us.